More than two weeks ago, it was reported that Teva Pharmaceutical Industries was going to lay off up to 1,700 workers, 25 percent of which to come from its 6,860-member Israeli workforce; and a 20 percent reduction of its global operations. Those numbers may be clarified today as Teva will hold a conference call on its restructuring plan.
According to a Reuters article, the plan includes closing Teva’s research and development center in the city of Netanya, selling its logistics center in Shoham and cutting 3,300 jobs out of 6,430 nationwide, an Israeli financial news website Calcalist reported.
Avi Nissenkorn, chief of the Histadrut labor federation, declared a half-day general strike in protest on Sunday, the story said.
“The entire economy - from the (Ben Gurion) airport to the banks to the seaports to the municipalities to the government service to the health clinics - will stand until noon on Sunday in solidarity with Teva’s employees,” Nissenkorn said.
Read the full story